The CD44/FKBPL ratio was also significantly reduced in preeclampsia cases compared to controls (Fig. 1C; 105.3 ng/mL ± 5.5 SEM vs 136.3 ng/mL ± 5.2, P < 0.001). This evidence concerns the gene CD44 and preeclampsia.